| Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673) |
|---|
| 06/15/2005 | CN1626532A Amide compounds |
| 06/15/2005 | CN1626526A Compound of alpha, beta and beta, gamma unsaturation carboxylate class of possessing weeding activity |
| 06/15/2005 | CN1206228C N-heterocyclic derivatives as NOS inhibitors |
| 06/14/2005 | US6906074 A tachykinin antagonist for used as antiinflammatory agent, antiallergic agent, analgesic, antiemetics, treating irritable colon syndrome, skin disorders |
| 06/14/2005 | US6906073 Piperazine CCR-3 receptor antagonists |
| 06/14/2005 | US6906072 Central nervous system disorders |
| 06/09/2005 | WO2005053048A1 Electroluminescent devices comprising 2-(p-triphenyl)-3-phenyl-pyrazine derivatives |
| 06/09/2005 | WO2005051926A1 Sulfoderivatives of acenaphtho[1,2-b]quinoxaline, lyotropic liquid crystal and anisotropic film on their base |
| 06/09/2005 | WO2005016286A3 Pyrazine modulators of cannabinoid receptors |
| 06/09/2005 | US20050124615 3-heteroarly-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b] indole-1-acetamide derivatives, preparation and use thereof in medicaments |
| 06/09/2005 | US20050124069 Transfection reagents |
| 06/09/2005 | US20050123831 used for ionic conducting materials, electronic conducting materials, colorant, and the catalysis of various chemical reactions |
| 06/08/2005 | EP1538150A1 Novel pleuromutilin derivatives |
| 06/08/2005 | EP1537098A1 Monocyclic derivatives as matrix metalloproteinase inhibitors |
| 06/08/2005 | EP1537074A1 Cathepsin cysteine protease inhibitors |
| 06/08/2005 | EP1465854A4 Chalcone derivatives and their use to treat diseases |
| 06/08/2005 | EP1370528B1 Mch antagonists and their use in the treatment of obesity |
| 06/08/2005 | EP1057816B1 Method for producing heteroaromatic aldehydes |
| 06/08/2005 | EP0849256B1 Amide compounds and use of the same |
| 06/08/2005 | CN1205185C Nitrogenous cyclic compounds and pharmaceutical compositions containing the same |
| 06/07/2005 | US6903215 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/07/2005 | US6903105 Nitrogen compounds such as 4-(4-(N-(3,5-diamino-6-chloro-pyrazine-2-carbonyl)guanidino)butyl)-N-(2 -aminoethyl)benzamide hydrochloride, administered for prophylaxis of respiratory system disorders; pharmocokinetics |
| 06/07/2005 | US6903088 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 06/02/2005 | WO2005049584A1 Acidic bath for electrolytically depositing a copper deposit containing halogenated or pseudohalogenated monomeric phenazinium compounds |
| 06/02/2005 | WO2005049583A1 Synthesis of 2-chloro-3,6-dialkyl pyrazines |
| 06/02/2005 | WO2005049573A1 Phenyl derivatives as ppar agonists |
| 06/02/2005 | WO2005016879A3 Cyclic pyrazinoylguanidine sodium channel blockers |
| 06/02/2005 | WO2005005606A3 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 06/02/2005 | WO2005005380A3 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 06/02/2005 | WO2004063150A3 Diagnostic and therapeutic alkyl piperidine/piperazine compounds and process |
| 06/02/2005 | US20050119275 Antiinflammatory agents; autoimmune disease; Alzheimer's disease; anticancer agents; antiarthritic agents; antidiabetic agents; lupus; interinflammatory agents |
| 06/02/2005 | US20050119252 Ligands of melanocortin receptors and compositions and methods related thereto |
| 06/02/2005 | US20050119250 Amino-derivatives as novel inhibitors of histone deacetylase |
| 06/02/2005 | US20050119227 Cyclic amine bace-1 inhibitors having a benzamide substituent |
| 06/02/2005 | US20050119225 Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogs |
| 06/02/2005 | CA2546026A1 Synthesis of 2-chloro-3,6-dialkyl pyrazines |
| 06/02/2005 | CA2545484A1 Processes for preparing tetrahydrobiopterin, and analogs of tetrahydrobiopterin |
| 06/02/2005 | CA2542356A1 Acidic bath for electrolytically depositing a copper deposit containing halogenated or pseudohalogenated monomeric phenazinium compounds |
| 06/01/2005 | EP1534693A2 1, 3-diamino-2-hydroxypropane prodrug derivatives |
| 06/01/2005 | EP1534692A1 Urea derivatives as kinase inhibitors |
| 06/01/2005 | EP1534391A1 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders |
| 06/01/2005 | EP1534273A2 Modulators of the glucocorticoid receptor and method |
| 06/01/2005 | EP1351959B1 Novel pleuromutilin derivatives |
| 06/01/2005 | EP1345902B1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same |
| 06/01/2005 | EP1095015B1 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators |
| 05/31/2005 | US6900345 Antibiotics; mutilin 14-[N-(2-carbamoyloxyethoxycarbonyl)]carbamate; therapy for bacteria infections; chemical synthesis |
| 05/31/2005 | US6900329 MCH antagonists and their use in the treatment of obesity |
| 05/31/2005 | US6900328 Stabilizer for polymers; photostability, oxidation resistance |
| 05/31/2005 | US6900319 Carbo- and heterocyclic amidines |
| 05/31/2005 | US6900213 Controlling fertility; contraceptives; anticancer agents |
| 05/26/2005 | WO2005047249A1 Benzylether amine compounds useful as ccr-5 antagonists |
| 05/26/2005 | WO2004046136A9 Pyrazine compounds as crf modulators |
| 05/26/2005 | US20050113574 Contains 1-(2-Aminoethyl)piperidine and 2-adamantanone; mycobacterial infections |
| 05/26/2005 | US20050113514 Chemical synthesis of pharmaceutical agents by amidation, cyclization; chemical intermediates; solid phase synthesis |
| 05/26/2005 | US20050113424 E.g., 4-{3-[4-(3-{4-[amino(imino)methyl]phenoxy}propyl)-1-piperazinyl]propoxy}benzamidine; an antifungal agent with good pharmacokinetics and excellent antifungal action; side effect reduction such as nephrotoxicity; action to Mycomycetes |
| 05/26/2005 | US20050113390 Treating diseases characterized by too little liquid on mucosal surfaces, applying topically on mucosal surface; increase potency, reduced mucosal absorption, and slow dissociation; long half-life on mucosal surfaces; pyrazinoylguanidine derivatives |
| 05/26/2005 | US20050113389 Sodium channel blockers |
| 05/26/2005 | US20050113388 Treating diseases characterized by too little liquid on mucosal surfaces using a"topical" sodium channel blocker designed to increased potency, reduced mucosal absorption, and slow dissociation; long half-life on mucosal surfaces; pyrazinoylguanidine derivatives |
| 05/26/2005 | US20050113373 medicine to inhibit proliferative conditions, such as cancer and psoriasis; detecting or identifying a histone deactylase (HDAC) in a biological sample |
| 05/26/2005 | US20050113366 Derivatives of 4-hydroxybutanoic acid and of its higher homologue as ligands of $g(g)-hydroxybutyrate (ghb) receptors, pharmaceutical compositions containing same and pharmaceutical uses |
| 05/26/2005 | US20050113344 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases |
| 05/26/2005 | US20050112693 Screening, biosynthesis of peptides |
| 05/26/2005 | US20050109986 Concurrent applying, molecular orientation; dissolving in solvent; applying to substrate; drying |
| 05/26/2005 | CA2543913A1 Benzylether amine compounds useful as ccr-5 antagonists |
| 05/25/2005 | EP1532209A2 Charge transport compositions and electronic devices made with such compositions |
| 05/25/2005 | EP1532097A2 Process for preparing (r)-aryloxypropionic acid ester derivatives |
| 05/25/2005 | EP1140814B1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 05/25/2005 | DE10352082A1 Hexylcarboxanilide Hexylcarboxanilides |
| 05/25/2005 | CN1620438A 5, 6-diaryl-pyrazine-2-amide derivatives as CBI antagonists |
| 05/24/2005 | US6897313 Production of 2-ethyl-3-methyl-1,4 diazine |
| 05/24/2005 | US6897312 Method for producing high melting point crystals of phenoxypropionic acid derivative |
| 05/24/2005 | US6897207 Kinase inhibitors; angiogenesis inhibitors, anticancer agents, antiinflammatory agents and chronic obstructive pulmonary disease inhibitors |
| 05/19/2005 | WO2005044201A2 Ph sensitive prodrugs of 2,6-diisopropylphenol |
| 05/19/2005 | WO2005028429A3 Haloalkyl containing compounds as cysteine protease inhibitors |
| 05/19/2005 | US20050107610 Synthesis of 2-chloro-3,6-dialkyl pyrazines |
| 05/19/2005 | US20050107397 Sulfonamide derivatives as d3-receptor agonists |
| 05/19/2005 | US20050107385 Aromatic prodrugs of propofol, compositions and uses thereof |
| 05/19/2005 | US20050107384 to inhibit proliferative conditions, such as cancer and psoriasis; detecting or identifying a HDAC in a biological sample comprising detecting or measuring the formation of a complex between a labelled compound as defined in claim (I) and a HDAC |
| 05/19/2005 | US20050107347 Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders |
| 05/19/2005 | US20050107321 FLK-1 is a receptor for vascular endothelial growth factor |
| 05/19/2005 | DE10348023A1 Neue Alanyl-Aminopeptidasen-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen New alanyl aminopeptidase inhibitors for functional interference of different cells and for the treatment of immunological, inflammatory, neuronal and other diseases |
| 05/19/2005 | DE10346939A1 New arylalkanol derivatives used for treating e.g. respiratory diseases, joint diseases, vascular inflammations, skin disorders, kidney and liver diseases and neurological diseases |
| 05/19/2005 | CA2543166A1 Ph sensitive prodrugs of 2,6-diisopropylphenol |
| 05/18/2005 | EP1530564A2 Compounds derived from aryl carbamates, preparation thereof and uses of same |
| 05/18/2005 | CN1617718A N-aryl-N'-arylcycloalkyl-urea derivatives as MCH antagonists for the treatment of obesity |
| 05/18/2005 | CN1616453A Antivirally active heterocyclic azahexane derivatives |
| 05/18/2005 | CN1202088C Process for simultaneously producing S-(+)-2-methykouoerazine and R-(-)-2-methylpiperazine by stepwise salification |
| 05/18/2005 | CN1201820C Compositions containing benzimidazolones and progestogens |
| 05/17/2005 | US6894050 3,4,5,6-tetrahydro-2h-(1,2')bipyrazinyl derivatives |
| 05/17/2005 | US6894049 Anticancer agents; water solubility |
| 05/17/2005 | US6893650 Fungicides; locus infestation; such as N,N-dimethyl-N'-(4-(3-trifluoromethylbenzylthio)-2,5-xylyl)formamidine |
| 05/17/2005 | CA2278455C Amine heat stable salt neutralization having reduced solids |
| 05/17/2005 | CA2103845C 9-[(substituted glycyl)-amido]-6-demethyl-6-deoxytetracyclines |
| 05/12/2005 | WO2005042516A2 Ligands of melanocortin receptors and compositions and methods related thereto |
| 05/12/2005 | WO2005042513A1 Phenyl carboxamide and sulfonamide derivatives for use as 11-beta-hydroxysteroid dehydrogenase |
| 05/12/2005 | WO2005042493A1 Hexyl carboxanilides and their use for controlling undesirable micro-organisms |
| 05/12/2005 | WO2005018644B1 Capped pyrazinoylguanidine sodium channel blockers |
| 05/12/2005 | WO2005018531A3 Pharmaceutical compositions, azo-heterocyclic compounds and method for the production and use thereof |
| 05/12/2005 | WO2004072087A3 Metal complexes as light-absorbing compounds in the information layer of optical data carriers |
| 05/12/2005 | US20050101783 N-(heterocycle-methyl)alkylamine derivative, process for producing the same, and bactericide |